Literature DB >> 22416600

Randomized trial of the Terumo Capiox FX05 oxygenator with integral arterial filter versus Terumo Capiox Baby RX05 and Terumo Capiox AF02 arterial filter in infants undergoing cardiopulmonary bypass.

Mark M Nuszkowski1, Nina Deutsch, Richard A Jonas, David Zurakowski, Erin Montague, David W Holt.   

Abstract

UNLABELLED: The purpose of this clinical trial was to evaluate the effect of the Terumo Capiox FX05 oxygenator with integrated arterial filter during cardiopulmonary bypass (CPB) compared with the Terumo Capiox RX05 Baby RX and arterial filter on inflammatory mediators and blood product utilization. Forty patients weighing less than 10 kg who underwent congenital heart surgery utilizing cardiopulmonary bypass were randomized into either oxygenator group. The endpoints included measuring inflammatory markers at six different time points (preoperative baseline, CPB circuit being primed, 15 minutes after CPB initiation, status post protamine administration, prior to transport to intensive care unit, and within 12 to 24 hours post surgery), blood product utilization, extubation time, and days until discharge. The inflammatory mediators showed no significant differences between oxygenators at any time points. However, looking at the inflammatory mediators of both the FX and RX groups combined, a statistically significant difference was seen in interleukin (IL)-6 at 12/24 hour post surgery (p < .001) versus baseline and all other time points. IL-8 at status post protamine (p < .001) and 12/24 hours post surgery (p < .001) demonstrated significant differences versus all other time points, and IL-10 at status post protamine (p < .001) and prior to leaving the operating room (p < .001) were statistically different compared to all other time points. Cardiopulmonary bypass stimulates the systemic inflammatory response through various components of the extracorporeal system. This investigation did not find significant differences in cytokines interferon-gamma, IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 p70, tumor necrosis factor (TNF)-alpha, and TNF-beta when comparing these two oxygenators. It is well known that various mechanisms contribute to the levels of cytokines circulating in a patient's blood volume and many manipulations throughout cardiac surgery have the ability to demonstrate anti-inflammatory interventions. Further investigation is needed as to how modification of the extracorporeal circuit may minimize increases in inflammatory mediators. KEYWORDS: infant, bypass, cytokines, blood, infant perfusion strategy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22416600      PMCID: PMC4557423     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  20 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

2.  Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis.

Authors:  Y M Bilgin; L M G van de Watering; L Eijsman; M I M Versteegh; M H J van Oers; A Brand
Journal:  Transfus Med       Date:  2007-08       Impact factor: 2.019

3.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function.

Authors:  B S Cain; D R Meldrum; C A Dinarello; X Meng; K S Joo; A Banerjee; A H Harken
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

Review 4.  Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation.

Authors:  S Wan; J L LeClerc; J L Vincent
Journal:  Ann Thorac Surg       Date:  1997-01       Impact factor: 4.330

5.  Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery.

Authors:  Y M Bilgin; L M G van de Watering; L Eijsman; M I M Versteegh; R Brand; M H J van Oers; A Brand
Journal:  Circulation       Date:  2004-05-17       Impact factor: 29.690

6.  Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries.

Authors:  Hedwig H Hövels-Gürich; Jaime F Vazquez-Jimenez; Anna Silvestri; Kathrin Schumacher; Ralf Minkenberg; Jean Duchateau; Bruno J Messmer; Götz von Bernuth; Marie-Christine Seghaye
Journal:  J Thorac Cardiovasc Surg       Date:  2002-10       Impact factor: 5.209

7.  Clinical gaseous microemboli assessment of an oxygenator with integral arterial filter in the pediatric population.

Authors:  Thomas J Preston; Daniel Gomez; Vincent F Olshove; Alistair Phillips; Mark Galantowicz
Journal:  J Extra Corpor Technol       Date:  2009-12

8.  Evaluation of air handling in a new generation neonatal oxygenator with integral arterial filter.

Authors:  D Gomez; T J Preston; V F Olshove; A B Phillips; M E Galantowicz
Journal:  Perfusion       Date:  2009-03       Impact factor: 1.972

9.  A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines.

Authors:  P Menasché; S Haydar; J Peynet; C Du Buit; R Merval; G Bloch; A Piwnica; A Tedgui
Journal:  J Thorac Cardiovasc Surg       Date:  1994-01       Impact factor: 5.209

10.  Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations.

Authors:  M Seghaye; J Duchateau; J Bruniaux; S Demontoux; C Bosson; A Serraf; G Lecronier; E Mokhfi; C Planche
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

View more
  3 in total

1.  Goal-Directed Perfusion Methodology for Determining Oxygenator Performance during Clinical Cardiopulmonary Bypass.

Authors:  Alfred H Stammers; Randi Miller; Stephen G Francis; Laszlo Fuzesi; Anthony Nostro; Eric Tesdahl
Journal:  J Extra Corpor Technol       Date:  2017-06

2.  Effects of Purge-Flow Rate on Microbubble Capture in Radial Arterial-Line Filters.

Authors:  Daniel P Herbst
Journal:  J Extra Corpor Technol       Date:  2016-09

Review 3.  Evolution of membrane oxygenator technology for utilization during pediatric cardiopulmonary bypass.

Authors:  Richard W Melchior; Steven W Sutton; William Harris; Heidi J Dalton
Journal:  Pediatric Health Med Ther       Date:  2016-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.